AK Medical Holdings Limited provides consolidated earnings guidance for the year ended 31 December 2022. For the period, The company expects to record an increase in revenue by over 35% for the year ended 31 December 2022 as compared to the revenue for the year ended 31 December 2021; and the Board expects to record a significant increase in net profit attributable to Shareholders by over 100% for the year ended 31 December 2022 as compared to the net profit attributable to Shareholders for the year ended 31 December 2021.